Earnings season is off and running, and that means many golden opportunities to check in with the most important stocks in the health care industry.
With new U.S. health care policies going into effect, pressures from European austerity pressuring sales in the Old World, and large but often uncertain opportunities presented in developing markets, there's a lot of noise to distract investors from company-specific dynamics at work.
In the following video, health care bureau chief Brenton Flynn tries to cut through the noise and offers some of his key takeaways from last week's St. Jude Medical earnings report.
One of the key drivers of cardiac medical devices is the obesity epidemic. Investors looking to invest in that trend might consider a look at the stocks behind newly approved pharmaceuticals for obesity. One of those stocks is Arena Pharmaceuticals. While the future looks bright for the company, there are still plenty of obstacles ahead. In our brand new premium research report on Arena Pharmaceuticals, we walk investors through the must know opportunities and threats facing the company. Since key news can develop quickly, we're also including a full year of updates for those who sign up. Click here now to learn more.
The article A Key Earnings Report in Cardiac Medical Devices originally appeared on Fool.com.Brenton Flynn has no position in any stocks mentioned. The Motley Fool owns shares of Medtronic and St. Jude Medical. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.